Skip to main content
. Author manuscript; available in PMC: 2024 Jun 17.
Published in final edited form as: Am J Obstet Gynecol. 2023 Oct 25;230(6):673.e1–673.e8. doi: 10.1016/j.ajog.2023.10.035

Table 5.

Complications and short-term morbidities of GBS EOS episodes based on type of prenatal antibiotic received for full term neonates with GBS positive mothers.

First-line antibiotics
(n = 51)
Second-line antibiotics
(n = 42)
No antibiotics
(n = 122)
p-value
Mortality 1 (2.0) 1 (2.4) 6 (4.9) .70
Tracheostomy at discharge 0 (0.0) 0 (0.0) 0 (0.0) -
Supplemental oxygen at discharge 3 (5.9) 0 (0.0) 0 (0.0) .02
Ventriculitis 0 (0.0) 0 (0.0) 0 (0.0) -
Septic Arthritis 0 (0.0) 0 (0.0) 0 (0.0) -
Cellulitis 0 (0.0) 0 (0.0) 1 (0.8) 1
Hydrocephalus 0 (0.0) 0 (0.0) 0 (0) -
Failed hearing 3 (5.9) 0 (0.0) 2 (1.6) .16

Data are presented as n (%) unless otherwise specified.

GBS, Group B Streptococcus; EOS, Early-Onset Sepsis.

Fisher’s exact test was used to compare for difference across groups by type of antibiotic received for each variable. p-values could not be calculated due to too few observations.